VADUZ, Liechtenstein, Feb. 14, 2025 /PRNewswire/ — RefluxStop™ FDA Milestone Significant events in the fourth quarter Submitted extensive clinical Module 2 of the 3 module-process in the Premarket Approval (PMA) application to U.S. FDA. Most crucial module containing clinical portion…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.